{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:14:04Z","timestamp":1790741644516,"version":"4.1.0"},"reference-count":150,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T00:00:00Z","timestamp":1688515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T00:00:00Z","timestamp":1688515200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Huntington\u2019s disease (HD) is a neurodegenerative disorder caused by CAG-repeat expansions in the huntingtin (<jats:italic>HTT<\/jats:italic>) gene. The resulting mutant HTT (mHTT) protein induces toxicity and cell death via multiple mechanisms and no effective therapy is available. Here, we employ a genome-wide screening in pluripotent mouse embryonic stem cells (ESCs) to identify suppressors of mHTT toxicity. Among the identified suppressors, linked to HD-associated processes, we focus on Metal response element binding transcription factor 1 (<jats:italic>Mtf1<\/jats:italic>). Forced expression of <jats:italic>Mtf1<\/jats:italic> counteracts cell death and oxidative stress caused by mHTT in mouse ESCs and in human neuronal precursor cells. In zebrafish, <jats:italic>Mtf1<\/jats:italic> reduces malformations and apoptosis induced by mHTT. In R6\/2 mice, <jats:italic>Mtf1<\/jats:italic> ablates motor defects and reduces mHTT aggregates and oxidative stress. Our screening strategy enables a quick in vitro identification of promising suppressor genes and their validation in vivo, and it can be applied to other monogenic diseases.<\/jats:p>","DOI":"10.1038\/s41467-023-39552-9","type":"journal-article","created":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T08:02:39Z","timestamp":1688544159000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Genome-wide screening in pluripotent cells identifies Mtf1 as a suppressor of mutant huntingtin toxicity"],"prefix":"10.1038","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1048-7708","authenticated-orcid":false,"given":"Giorgia Maria","family":"Ferlazzo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2342-3051","authenticated-orcid":false,"given":"Anna Maria","family":"Gambetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8984-8239","authenticated-orcid":false,"given":"Sonia","family":"Amato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0071-6291","authenticated-orcid":false,"given":"Noemi","family":"Cannizzaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Angiolillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7286-5589","authenticated-orcid":false,"given":"Mattia","family":"Arboit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3268-1707","authenticated-orcid":false,"given":"Linda","family":"Diamante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6591-6915","authenticated-orcid":false,"given":"Elena","family":"Carbognin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1149-4304","authenticated-orcid":false,"given":"Patrizia","family":"Romani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7843-5761","authenticated-orcid":false,"given":"Federico","family":"La Torre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Galimberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5344-5359","authenticated-orcid":false,"given":"Florian","family":"Pflug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5006-1827","authenticated-orcid":false,"given":"Mirko","family":"Luoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6787-7793","authenticated-orcid":false,"given":"Serena","family":"Giannelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Pepe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Capocci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba","family":"Di Pardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9444-3579","authenticated-orcid":false,"given":"Paola","family":"Vanzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6127-9912","authenticated-orcid":false,"given":"Lucio","family":"Zennaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4050-0926","authenticated-orcid":false,"given":"Vania","family":"Broccoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5114-4782","authenticated-orcid":false,"given":"Martin","family":"Leeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3166-8102","authenticated-orcid":false,"given":"Enrico","family":"Moro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6906-7372","authenticated-orcid":false,"given":"Vittorio","family":"Maglione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5520-085X","authenticated-orcid":false,"given":"Graziano","family":"Martello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,5]]},"reference":[{"key":"39552_CR1","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1159\/000443738","volume":"46","author":"MD Rawlins","year":"2016","unstructured":"Rawlins, M. D. et al. The prevalence of huntington\u2019s disease. Neuroepidemiology 46, 144\u2013153 (2016).","journal-title":"Neuroepidemiology"},{"key":"39552_CR2","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/S1474-4422(10)70160-5","volume":"9","author":"L Spinney","year":"2010","unstructured":"Spinney, L. Uncovering the true prevalence of Huntington\u2019s disease. Lancet Neurol 9, 760\u2013761 (2010).","journal-title":"Lancet Neurol"},{"key":"39552_CR3","first-page":"615","volume":"45","author":"RH Myers","year":"1989","unstructured":"Myers, R. H. et al. Homozygote for Huntington disease. Am. J. Hum. Genet. 45, 615\u2013618 (1989).","journal-title":"Am. J. Hum. Genet."},{"key":"39552_CR4","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"ME MacDonald","year":"1993","unstructured":"MacDonald, M. E. et al. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. Cell 72, 971\u2013983 (1993).","journal-title":"Cell"},{"key":"39552_CR5","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1126\/science.7618107","volume":"269","author":"M Duyao","year":"1995","unstructured":"Duyao, M. et al. Inactivation of the mouse Huntington\u2019s disease gene homolog Hdh. Science 269, 407\u2013410 (1995).","journal-title":"Science"},{"key":"39552_CR6","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/0092-8674(95)90542-1","volume":"81","author":"J Nasir","year":"1995","unstructured":"Nasir, J. et al. Targeted disruption of the Huntington\u2019s disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes. Cell 81, 811\u2013823 (1995).","journal-title":"Cell"},{"key":"39552_CR7","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/ng1095-155","volume":"11","author":"S Zeitlin","year":"1995","unstructured":"Zeitlin, S., Liu, J. P., Chapman, D. L., Papaioannou, V. E. & Efstratiadis, A. Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington\u2019s disease gene homologue. Nat. Genet. 11, 155\u2013163 (1995).","journal-title":"Nat. Genet."},{"key":"39552_CR8","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/jnc.12348","volume":"127","author":"P Conforti","year":"2013","unstructured":"Conforti, P. et al. Binding of the repressor complex REST-mSIN3b by small molecules restores neuronal gene transcription in Huntington\u2019s disease models. J. Neurochem. 127, 22\u201335 (2013).","journal-title":"J. Neurochem."},{"key":"39552_CR9","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/nn.3080","volume":"15","author":"V Lo Sardo","year":"2012","unstructured":"Lo Sardo, V. et al. An evolutionary recent neuroepithelial cell adhesion function of huntingtin implicates ADAM10-Ncadherin. Nat. Neurosci. 15, 713\u2013721 (2012).","journal-title":"Nat. Neurosci."},{"key":"39552_CR10","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1126\/science.1056784","volume":"291","author":"FC Nucifora","year":"2001","unstructured":"Nucifora, F. C. et al. Interference by Huntingtin and Atrophin-1 with CBP-Mediated Transcription Leading to Cellular Toxicity. Science 291, 2423\u20132428 (2001).","journal-title":"Science"},{"key":"39552_CR11","doi-asserted-by":"publisher","first-page":"3705","DOI":"10.1523\/JNEUROSCI.20-10-03705.2000","volume":"20","author":"D Rigamonti","year":"2000","unstructured":"Rigamonti, D. et al. Wild-type huntingtin protects from apoptosis upstream of caspase-3. J. Neurosci. Off. J. Soc. Neurosci. 20, 3705\u20133713 (2000).","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"39552_CR12","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","volume":"277","author":"M DiFiglia","year":"1997","unstructured":"DiFiglia, M. et al. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277, 1990\u20131993 (1997).","journal-title":"Science"},{"key":"39552_CR13","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1096\/fj.12-219220","volume":"27","author":"B Lu","year":"2013","unstructured":"Lu, B. & Palacino, J. A novel human embryonic stem cell-derived Huntington\u2019s disease neuronal model exhibits mutant huntingtin (mHTT) aggregates and soluble mHTT-dependent neurodegeneration. FASEB J 27, 1820\u20131829 (2013).","journal-title":"FASEB J"},{"key":"39552_CR14","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","volume":"10","author":"CA Ross","year":"2011","unstructured":"Ross, C. A. & Tabrizi, S. J. Huntington\u2019s disease: from molecular pathogenesis to clinical treatment. Lancet Neurol 10, 83\u201398 (2011).","journal-title":"Lancet Neurol"},{"key":"39552_CR15","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1152\/physrev.00041.2009","volume":"90","author":"C Zuccato","year":"2010","unstructured":"Zuccato, C., Valenza, M. & Cattaneo, E. Molecular Mechanisms and Potential Therapeutical Targets in Huntington\u2019s Disease. Physiol. Rev. 90, 905\u2013981 (2010).","journal-title":"Physiol. Rev."},{"key":"39552_CR16","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1093\/hmg\/2.12.2069","volume":"2","author":"AT Hoogeveen","year":"1993","unstructured":"Hoogeveen, A. T. et al. Characterization and localization of the Huntington disease gene product. Hum. Mol. Genet. 2, 2069\u20132073 (1993).","journal-title":"Hum. Mol. Genet."},{"key":"39552_CR17","doi-asserted-by":"publisher","first-page":"5733","DOI":"10.1073\/pnas.85.15.5733","volume":"85","author":"A Reiner","year":"1988","unstructured":"Reiner, A. et al. Differential loss of striatal projection neurons in Huntington disease. Proc. Natl. Acad. Sci. USA. 85, 5733\u20135737 (1988).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"39552_CR18","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1196\/annals.1427.034","volume":"1147","author":"HD Rosas","year":"2008","unstructured":"Rosas, H. D. et al. Complexity and heterogeneity: what drives the ever-changing brain in Huntington\u2019s disease? Ann. N. Y. Acad. Sci 1147, 196\u2013205 (2008).","journal-title":"Ann. N. Y. Acad. Sci"},{"key":"39552_CR19","doi-asserted-by":"publisher","unstructured":"Birolini, G. et al. Striatal infusion of cholesterol promotes dose-dependent behavioral benefits and exerts disease-modifying effects in Huntington\u2019s disease mice. EMBO Mol. Med. e12519 (2020) https:\/\/doi.org\/10.15252\/emmm.202012519.","DOI":"10.15252\/emmm.202012519"},{"key":"39552_CR20","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1093\/hmg\/ddt615","volume":"23","author":"A Di Pardo","year":"2014","unstructured":"Di Pardo, A. et al. FTY720 (fingolimod) is a neuroprotective and disease-modifying agent in cellular and mouse models of Huntington disease. Hum. Mol. Genet 23, 2251\u20132265 (2014).","journal-title":"Hum. Mol. Genet"},{"key":"39552_CR21","doi-asserted-by":"publisher","first-page":"9152","DOI":"10.1523\/JNEUROSCI.3001-05.2005","volume":"25","author":"VM Miller","year":"2005","unstructured":"Miller, V. M. et al. CHIP Suppresses Polyglutamine Aggregation and Toxicity In Vitro and In Vivo. J. Neurosci. 25, 9152\u20139161 (2005).","journal-title":"J. Neurosci."},{"key":"39552_CR22","doi-asserted-by":"publisher","first-page":"3425","DOI":"10.1093\/hmg\/ddi372","volume":"14","author":"C Vacher","year":"2005","unstructured":"Vacher, C., Garcia-Oroz, L. & Rubinsztein, D. C. Overexpression of yeast hsp104 reduces polyglutamine aggregation and prolongs survival of a transgenic mouse model of Huntington\u2019s disease. Hum. Mol. Genet 14, 3425\u20133433 (2005).","journal-title":"Hum. Mol. Genet"},{"key":"39552_CR23","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/cdd.2014.162","volume":"22","author":"M Valenza","year":"2015","unstructured":"Valenza, M. et al. Disruption of astrocyte-neuron cholesterol cross talk affects neuronal function in Huntington\u2019s disease. Cell Death Differ 22, 690\u2013702 (2015).","journal-title":"Cell Death Differ"},{"key":"39552_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrdp.2015.5","volume":"1","author":"GP Bates","year":"2015","unstructured":"Bates, G. P. et al. Huntington disease. Nat. Rev. Dis. Primer 1, 1\u201321 (2015).","journal-title":"Nat. Rev. Dis. Primer"},{"key":"39552_CR25","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1093\/hmg\/ddv006","volume":"24","author":"M Biagioli","year":"2015","unstructured":"Biagioli, M. et al. Htt CAG repeat expansion confers pleiotropic gains of mutant huntingtin function in chromatin regulation. Hum. Mol. Genet 24, 2442\u20132457 (2015).","journal-title":"Hum. Mol. Genet"},{"key":"39552_CR26","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.ydbio.2014.04.005","volume":"391","author":"I Ismailoglu","year":"2014","unstructured":"Ismailoglu, I. et al. Huntingtin protein is essential for mitochondrial metabolism, bioenergetics and structure in murine embryonic stem cells. Dev. Biol. 391, 230\u2013240 (2014).","journal-title":"Dev. Biol."},{"key":"39552_CR27","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/S0092-8674(03)00392-1","volume":"113","author":"I Chambers","year":"2003","unstructured":"Chambers, I. et al. Functional expression cloning of nanog, a pluripotency sustaining factor in embryonic stem. Cells. Cell 113, 643\u2013655 (2003).","journal-title":"Cells. Cell"},{"key":"39552_CR28","doi-asserted-by":"publisher","first-page":"9195","DOI":"10.1074\/jbc.M607865200","volume":"282","author":"NW Schiffer","year":"2007","unstructured":"Schiffer, N. W. et al. Identification of anti-prion compounds as efficient inhibitors of polyglutamine protein aggregation in a Zebrafish model. J. Biol. Chem. 282, 9195\u20139203 (2007).","journal-title":"J. Biol. Chem."},{"key":"39552_CR29","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","volume":"87","author":"L Mangiarini","year":"1996","unstructured":"Mangiarini, L. et al. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87, 493\u2013506 (1996).","journal-title":"Cell"},{"key":"39552_CR30","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1093\/hmg\/ddq026","volume":"19","author":"MA Pouladi","year":"2010","unstructured":"Pouladi, M. A. et al. Full-length huntingtin levels modulate body weight by influencing insulin-like growth factor 1 expression. Hum. Mol. Genet. 19, 1528\u20131538 (2010).","journal-title":"Hum. Mol. Genet."},{"key":"39552_CR31","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1093\/hmg\/9.19.2799","volume":"9","author":"F Trettel","year":"2000","unstructured":"Trettel, F. et al. Dominant phenotypes produced by the HD mutation in STHdhQ111 striatal cells. Hum. Mol. Genet 9, 2799\u20132809 (2000).","journal-title":"Hum. Mol. Genet"},{"key":"39552_CR32","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/j.1471-4159.2009.06445.x","volume":"112","author":"BB Williams","year":"2010","unstructured":"Williams, B. B. et al. Disease-toxicant screen reveals a neuroprotective interaction between Huntington\u2019s disease and manganese exposure. J. Neurochem 112, 227\u2013237 (2010).","journal-title":"J. Neurochem"},{"key":"39552_CR33","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/ng1297-404","volume":"17","author":"JK White","year":"1997","unstructured":"White, J. K. et al. Huntingtin is required for neurogenesis and is not impaired by the Huntington\u2019s disease CAG expansion. Nat. Genet. 17, 404\u2013410 (1997).","journal-title":"Nat. Genet."},{"key":"39552_CR34","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.1093\/hmg\/ddr195","volume":"20","author":"JC Jacobsen","year":"2011","unstructured":"Jacobsen, J. C. et al. HD CAG-correlated gene expression changes support a simple dominant gain of function. Hum. Mol. Genet 20, 2846\u20132860 (2011).","journal-title":"Hum. Mol. Genet"},{"key":"39552_CR35","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1093\/hmg\/9.4.503","volume":"9","author":"VC Wheeler","year":"2000","unstructured":"Wheeler, V. C. et al. Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in HdhQ92 and HdhQ111 knock-in mice. Hum. Mol. Genet 9, 503\u2013513 (2000).","journal-title":"Hum. Mol. Genet"},{"key":"39552_CR36","doi-asserted-by":"publisher","first-page":"ra103","DOI":"10.1126\/scisignal.2005633","volume":"7","author":"WM Pryor","year":"2014","unstructured":"Pryor, W. M. et al. Huntingtin promotes mTORC1 signaling in the pathogenesis of Huntington\u2019s disease. Sci. Signal. 7, ra103 (2014).","journal-title":"Sci. Signal."},{"key":"39552_CR37","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.stem.2012.04.027","volume":"11","author":"HD iPSC","year":"2012","unstructured":"iPSC, H. D. Consortium. Induced pluripotent stem cells from patients with Huntington\u2019s disease show CAG-repeat-expansion-associated phenotypes. Cell Stem Cell 11, 264\u2013278 (2012).","journal-title":"Cell Stem Cell"},{"key":"39552_CR38","doi-asserted-by":"publisher","first-page":"2944","DOI":"10.1007\/s12035-015-9188-0","volume":"53","author":"N Brustovetsky","year":"2016","unstructured":"Brustovetsky, N. Mutant Huntingtin and Elusive Defects in Oxidative Metabolism and Mitochondrial Calcium Handling. Mol. Neurobiol. 53, 2944\u20132953 (2016).","journal-title":"Mol. Neurobiol."},{"key":"39552_CR39","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.neuint.2017.04.012","volume":"109","author":"I Salvatori","year":"2017","unstructured":"Salvatori, I., Valle, C., Ferri, A. & Carr\u00ec, M. T. SIRT3 and mitochondrial metabolism in neurodegenerative diseases. Neurochem. Int. 109, 184\u2013192 (2017).","journal-title":"Neurochem. Int."},{"key":"39552_CR40","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1385\/NMM:4:1-2:7","volume":"4","author":"ME MacDonald","year":"2003","unstructured":"MacDonald, M. E., Gines, S., Gusella, J. F. & Wheeler, V. C. Huntington\u2019s disease. NeuroMolecular Med 4, 7\u201320 (2003).","journal-title":"NeuroMolecular Med"},{"key":"39552_CR41","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1089\/ars.2013.5802","volume":"21","author":"C McKinnon","year":"2014","unstructured":"McKinnon, C. & Tabrizi, S. J. The Ubiquitin-proteasome system in neurodegeneration. Antioxid. Redox Signal. 21, 2302\u20132321 (2014).","journal-title":"Antioxid. Redox Signal."},{"key":"39552_CR42","doi-asserted-by":"publisher","unstructured":"Bichell, T. J. V., Halbesma, T. C., Tipps, K. G. & Bowman, A. B. Chapter 13 - Metal Biology Associated with Huntington\u2019s Disease. in Biometals in Neurodegenerative Diseases (eds. White, A. R., Aschner, M., Costa, L. G. & Bush, A. I.) 231\u2013263 (Academic Press, 2017). https:\/\/doi.org\/10.1016\/B978-0-12-804562-6.00013-0.","DOI":"10.1016\/B978-0-12-804562-6.00013-0"},{"key":"39552_CR43","doi-asserted-by":"publisher","first-page":"6727","DOI":"10.1039\/C4CS00138A","volume":"43","author":"KJ Barnham","year":"2014","unstructured":"Barnham, K. J. & Bush, A. I. Biological metals and metal-targeting compounds in major neurodegenerative diseases. Chem. Soc. Rev. 43, 6727\u20136749 (2014).","journal-title":"Chem. Soc. Rev."},{"key":"39552_CR44","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1001\/archneurol.2011.2945","volume":"69","author":"HD Rosas","year":"2012","unstructured":"Rosas, H. D. et al. Alterations in brain transition metals in huntington disease: an evolving and intricate story. Arch. Neurol. 69, 887\u2013893 (2012).","journal-title":"Arch. Neurol."},{"key":"39552_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/2050-7771-1-28","volume":"1","author":"D Diamanti","year":"2013","unstructured":"Diamanti, D. et al. Whole gene expression profile in blood reveals multiple pathways deregulation in R6\/2 mouse model. Biomark. Res. 1, 28 (2013).","journal-title":"Biomark. Res."},{"key":"39552_CR46","doi-asserted-by":"publisher","first-page":"661612","DOI":"10.3389\/fncel.2021.661612","volume":"15","author":"W Guiler","year":"2021","unstructured":"Guiler, W., Koehler, A., Boykin, C. & Lu, Q. Pharmacological modulators of small GTPases of Rho family in neurodegenerative diseases. Front. Cell. Neurosci. 15, 661612 (2021).","journal-title":"Front. Cell. Neurosci."},{"key":"39552_CR47","first-page":"bat018","volume":"2013","author":"N Rappaport","year":"2013","unstructured":"Rappaport, N. et al. MalaCards: an integrated compendium for diseases and their annotation. Database J. Biol. Databases Curation 2013, bat018 (2013).","journal-title":"Database J. Biol. Databases Curation"},{"key":"39552_CR48","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1136\/jnnp.70.5.657","volume":"70","author":"LH Pinborg","year":"2001","unstructured":"Pinborg, L. H. et al. Benzodiazepine receptor quantification in Huntington\u2019s disease with [(123)I]iomazenil and SPECT. J. Neurol. Neurosurg. Psychiatry 70, 657\u2013661 (2001).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"39552_CR49","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1002\/ana.410340114","volume":"34","author":"VA Holthoff","year":"1993","unstructured":"Holthoff, V. A. et al. Positron emission tomography measures of benzodiazepine receptors in Huntington\u2019s disease. Ann. Neurol. 34, 76\u201381 (1993).","journal-title":"Ann. Neurol."},{"key":"39552_CR50","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1002\/1531-8249(200005)47:5<644::AID-ANA13>3.0.CO;2-C","volume":"47","author":"G K\u00fcnig","year":"2000","unstructured":"K\u00fcnig, G. et al. Benzodiazepine receptor binding in Huntington\u2019s disease: [11C]flumazenil uptake measured using positron emission tomography. Ann. Neurol. 47, 644\u2013648 (2000).","journal-title":"Ann. Neurol."},{"key":"39552_CR51","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.tins.2014.09.003","volume":"38","author":"DDO Martin","year":"2015","unstructured":"Martin, D. D. O., Ladha, S., Ehrnhoefer, D. E. & Hayden, M. R. Autophagy in Huntington disease and huntingtin in autophagy. Trends Neurosci 38, 26\u201335 (2015).","journal-title":"Trends Neurosci"},{"key":"39552_CR52","doi-asserted-by":"publisher","first-page":"19831","DOI":"10.1074\/jbc.M001475200","volume":"275","author":"CL Wellington","year":"2000","unstructured":"Wellington, C. L. et al. Inhibiting Caspase Cleavage of Huntingtin Reduces Toxicity and Aggregate Formation in Neuronal and Nonneuronal Cells. J. Biol. Chem. 275, 19831\u201319838 (2000).","journal-title":"J. Biol. Chem."},{"key":"39552_CR53","doi-asserted-by":"publisher","first-page":"2898","DOI":"10.1073\/pnas.97.6.2898","volume":"97","author":"A Wyttenbach","year":"2000","unstructured":"Wyttenbach, A. et al. Effects of heat shock, heat shock protein 40 (HDJ-2), and proteasome inhibition on protein aggregation in cellular models of Huntington\u2019s disease. Proc. Natl. Acad. Sci. USA. 97, 2898\u20132903 (2000).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"39552_CR54","first-page":"3185","volume":"137","author":"G Guo","year":"2010","unstructured":"Guo, G. & Smith, A. A genome-wide screen in EpiSCs identifies Nr5a nuclear receptors as potent inducers of ground state pluripotency. Dev. Camb. Engl 137, 3185\u20133192 (2010).","journal-title":"Dev. Camb. Engl"},{"key":"39552_CR55","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.stem.2013.12.008","volume":"14","author":"M Leeb","year":"2014","unstructured":"Leeb, M., Dietmann, S., Paramor, M., Niwa, H. & Smith, A. Genetic exploration of the exit from self-renewal using haploid embryonic stem cells. Cell Stem Cell 14, 385\u2013393 (2014).","journal-title":"Cell Stem Cell"},{"key":"39552_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-05224-0","volume":"7","author":"RKR Kalathur","year":"2017","unstructured":"Kalathur, R. K. R., Pedro Pinto, J., Sahoo, B., Chaurasia, G. & Futschik, M. E. HDNetDB: A molecular interaction database for network-oriented investigations into Huntington\u2019s disease. Sci. Rep. 7, 5216 (2017).","journal-title":"Sci. Rep."},{"key":"39552_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-12-47","volume":"12","author":"RKR Kalathur","year":"2012","unstructured":"Kalathur, R. K. R., Hern\u00e1ndez-Prieto, M. A. & Futschik, M. E. Huntington\u2019s disease and its therapeutic target genes: a global functional profile based on the HD Research Crossroads database. BMC Neurol 12, 47 (2012).","journal-title":"BMC Neurol"},{"key":"39552_CR58","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/ng0504-431","volume":"36","author":"KG Becker","year":"2004","unstructured":"Becker, K. G., Barnes, K. C., Bright, T. J. & Wang, S. A. The genetic association database. Nat. Genet. 36, 431\u2013432 (2004).","journal-title":"Nat. Genet."},{"key":"39552_CR59","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-13-71","volume":"13","author":"X Chen","year":"2012","unstructured":"Chen, X. & Burgoyne, R. D. Identification of common genetic modifiers of neurodegenerative diseases from an integrative analysis of diverse genetic screens in model organisms. BMC Genomics 13, 71 (2012).","journal-title":"BMC Genomics"},{"key":"39552_CR60","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1016\/j.bbamcr.2012.01.005","volume":"1823","author":"V G\u00fcnther","year":"2012","unstructured":"G\u00fcnther, V., Lindert, U. & Schaffner, W. The taste of heavy metals: Gene regulation by MTF-1. Biochim. Biophys. Acta BBA - Mol. Cell Res. 1823, 1416\u20131425 (2012).","journal-title":"Biochim. Biophys. Acta BBA - Mol. Cell Res."},{"key":"39552_CR61","doi-asserted-by":"publisher","first-page":"5715","DOI":"10.1093\/nar\/gki881","volume":"33","author":"U Wimmer","year":"2005","unstructured":"Wimmer, U., Wang, Y., Georgiev, O. & Schaffner, W. Two major branches of anti-cadmium defense in the mouse: MTF-1\/metallothioneins and glutathione. Nucleic Acids Res 33, 5715\u20135727 (2005).","journal-title":"Nucleic Acids Res"},{"key":"39552_CR62","doi-asserted-by":"publisher","first-page":"6044","DOI":"10.3390\/ijms14036044","volume":"14","author":"B Ruttkay-Nedecky","year":"2013","unstructured":"Ruttkay-Nedecky, B. et al. The Role of Metallothionein in Oxidative Stress. Int. J. Mol. Sci. 14, 6044\u20136066 (2013).","journal-title":"Int. J. Mol. Sci."},{"key":"39552_CR63","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.1093\/emboj\/17.10.2846","volume":"17","author":"\u00c7 G\u00fcnes","year":"1998","unstructured":"G\u00fcnes, \u00c7. et al. Embryonic lethality and liver degeneration in mice lacking the metal-responsive transcriptional activator MTF-1. EMBO J 17, 2846\u20132854 (1998).","journal-title":"EMBO J"},{"key":"39552_CR64","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1002\/bies.1146","volume":"23","author":"P Lichtlen","year":"2001","unstructured":"Lichtlen, P. & Schaffner, W. Putting its fingers on stressful situations: the heavy metal-regulatory transcription factor MTF-1. BioEssays News Rev. Mol. Cell. Dev. Biol 23, 1010\u20131017 (2001).","journal-title":"BioEssays News Rev. Mol. Cell. Dev. Biol"},{"key":"39552_CR65","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1089\/15230860152542943","volume":"3","author":"DP Giedroc","year":"2001","unstructured":"Giedroc, D. P., Chen, X. & Apuy, J. L. Metal response element (MRE)-binding transcription factor-1 (MTF-1): structure, function, and regulation. Antioxid. Redox Signal. 3, 577\u2013596 (2001).","journal-title":"Antioxid. Redox Signal."},{"key":"39552_CR66","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.3892\/mmr.2014.2969","volume":"11","author":"G Dong","year":"2015","unstructured":"Dong, G., Chen, H., Qi, M., Dou, Y. & Wang, Q. Balance between metallothionein and metal response element binding transcription factor 1 is mediated by zinc ions (review). Mol. Med. Rep 11, 1582\u20131586 (2015).","journal-title":"Mol. Med. Rep"},{"key":"39552_CR67","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1379\/1466-1268(2000)005<0196:COTMGF>2.0.CO;2","volume":"5","author":"AA der Maur","year":"2000","unstructured":"der Maur, A. A. et al. Characterization of the mouse gene for the heavy metal-responsive transcription factor MTF-1. Cell Stress Chaperones 5, 196\u2013206 (2000).","journal-title":"Cell Stress Chaperones"},{"key":"39552_CR68","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.neuro.2018.10.012","volume":"70","author":"GF Kwakye","year":"2019","unstructured":"Kwakye, G. F. et al. Heterozygous huntingtin promotes cadmium neurotoxicity and neurodegeneration in striatal cells via altered metal transport and protein kinase C delta dependent oxidative stress and apoptosis signaling mechanisms. NeuroToxicology 70, 48\u201361 (2019).","journal-title":"NeuroToxicology"},{"key":"39552_CR69","doi-asserted-by":"publisher","first-page":"898034","DOI":"10.1155\/2013\/898034","volume":"2013","author":"B Wang","year":"2013","unstructured":"Wang, B. & Du, Y. Cadmium and its neurotoxic effects. Oxid. Med. Cell. Longev. 2013, 898034 (2013).","journal-title":"Oxid. Med. Cell. Longev."},{"key":"39552_CR70","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1136\/jmg.36.10.739","volume":"36","author":"Y Narain","year":"1999","unstructured":"Narain, Y., Wyttenbach, A., Rankin, J., Furlong, R. A. & Rubinsztein, D. C. A molecular investigation of true dominance in Huntington\u2019s disease. J. Med. Genet. 36, 739\u2013746 (1999).","journal-title":"J. Med. Genet."},{"key":"39552_CR71","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1006\/dbio.2001.0432","volume":"240","author":"LK Cole","year":"2001","unstructured":"Cole, L. K. & Ross, L. S. Apoptosis in the Developing Zebrafish Embryo. Dev. Biol. 240, 123\u2013142 (2001).","journal-title":"Dev. Biol."},{"key":"39552_CR72","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S0166-4328(01)00261-3","volume":"126","author":"H-G L\u00fcesse","year":"2001","unstructured":"L\u00fcesse, H.-G. et al. Evaluation of R6\/2 HD transgenic mice for therapeutic studies in Huntington\u2019s disease: behavioral testing and impact of diabetes mellitus. Behav. Brain Res 126, 185\u2013195 (2001).","journal-title":"Behav. Brain Res"},{"key":"39552_CR73","doi-asserted-by":"publisher","first-page":"3248","DOI":"10.1523\/JNEUROSCI.19-08-03248.1999","volume":"19","author":"RJ Carter","year":"1999","unstructured":"Carter, R. J. et al. Characterization of progressive motor deficits in mice transgenic for the human Huntington\u2019s disease mutation. J. Neurosci. 19, 3248\u20133257 (1999).","journal-title":"J. Neurosci."},{"key":"39552_CR74","doi-asserted-by":"publisher","first-page":"8093","DOI":"10.1073\/pnas.110078997","volume":"97","author":"M Turmaine","year":"2000","unstructured":"Turmaine, M. et al. Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington\u2019s disease. Proc. Natl. Acad. Sci. USA. 97, 8093\u20138097 (2000).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"39552_CR75","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.1016\/j.ymthe.2017.08.004","volume":"25","author":"G Morabito","year":"2017","unstructured":"Morabito, G. et al. AAV-PHP.B-Mediated Global-Scale Expression in the Mouse Nervous System Enables GBA1 Gene Therapy for Wide Protection from Synucleinopathy. Mol. Ther. 25, 2727\u20132742 (2017).","journal-title":"Mol. Ther."},{"key":"39552_CR76","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1038\/nn.4593","volume":"20","author":"KY Chan","year":"2017","unstructured":"Chan, K. Y. et al. Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems. Nat. Neurosci. 20, 1172\u20131179 (2017).","journal-title":"Nat. Neurosci."},{"key":"39552_CR77","doi-asserted-by":"publisher","first-page":"e52629","DOI":"10.7554\/eLife.52629","volume":"9","author":"M Luoni","year":"2020","unstructured":"Luoni, M. et al. Whole brain delivery of an instability-prone Mecp2 transgene improves behavioral and molecular pathological defects in mouse models of Rett syndrome. eLife 9, e52629 (2020).","journal-title":"eLife"},{"key":"39552_CR78","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nrn2652","volume":"10","author":"SP Brooks","year":"2009","unstructured":"Brooks, S. P. & Dunnett, S. B. Tests to assess motor phenotype in mice: a user\u2019s guide. Nat. Rev. Neurosci. 10, 519\u2013529 (2009).","journal-title":"Nat. Rev. Neurosci."},{"key":"39552_CR79","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1093\/hmg\/ddy153","volume":"27","author":"A Di Pardo","year":"2018","unstructured":"Di Pardo, A. et al. Stimulation of S1PR5 with A-971432, a selective agonist, preserves blood-brain barrier integrity and exerts therapeutic effect in an animal model of Huntington\u2019s disease. Hum. Mol. Genet 27, 2490\u20132501 (2018).","journal-title":"Hum. Mol. Genet"},{"key":"39552_CR80","doi-asserted-by":"crossref","unstructured":"Dodds, L., Chen, J., Berggren, K. & Fox, J. Characterization of Striatal Neuronal Loss and Atrophy in the R6\/2 Mouse Model of Huntington\u2019s Disease. PLoS Curr. 6, ecurrents.hd.48727b68b39 b82d5fe350f753984bcf9 (2014).","DOI":"10.1371\/currents.hd.48727b68b39b82d5fe350f753984bcf9"},{"key":"39552_CR81","doi-asserted-by":"publisher","first-page":"15005","DOI":"10.1038\/nrdp.2015.5","volume":"1","author":"GP Bates","year":"2015","unstructured":"Bates, G. P. et al. Huntington disease. Nat. Rev. Dis. Primer 1, 15005 (2015).","journal-title":"Nat. Rev. Dis. Primer"},{"key":"39552_CR82","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/s41582-020-0389-4","volume":"16","author":"SJ Tabrizi","year":"2020","unstructured":"Tabrizi, S. J., Flower, M. D., Ross, C. A. & Wild, E. J. Huntington disease: new insights into molecular pathogenesis and therapeutic opportunities. Nat. Rev. Neurol. 16, 529\u2013546 (2020).","journal-title":"Nat. Rev. Neurol."},{"key":"39552_CR83","doi-asserted-by":"publisher","first-page":"E3896","DOI":"10.3390\/ijms20163896","volume":"20","author":"E L\u00e9vy","year":"2019","unstructured":"L\u00e9vy, E. et al. Causative links between protein aggregation and oxidative stress: a review. Int. J. Mol. Sci. 20, E3896 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"39552_CR84","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2741\/s474","volume":"9","author":"S Ahmad","year":"2017","unstructured":"Ahmad, S. et al. Protein oxidation: an overview of metabolism of sulphur containing amino acid, cysteine. Front. Biosci.-Sch. 9, 71\u201387 (2017).","journal-title":"Front. Biosci.-Sch."},{"key":"39552_CR85","doi-asserted-by":"publisher","first-page":"2494","DOI":"10.1016\/j.celrep.2019.02.008","volume":"26","author":"J Ooi","year":"2019","unstructured":"Ooi, J. et al. Unbiased profiling of isogenic huntington disease hPSC-derived CNS and peripheral cells reveals strong cell-type specificity of CAG length effects. Cell Rep 26, 2494\u20132508.e7 (2019).","journal-title":"Cell Rep"},{"key":"39552_CR86","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.stem.2012.04.026","volume":"11","author":"MC An","year":"2012","unstructured":"An, M. C. et al. Genetic correction of Huntington\u2019s disease phenotypes in induced pluripotent stem cells. Cell Stem Cell 11, 253\u2013263 (2012).","journal-title":"Cell Stem Cell"},{"key":"39552_CR87","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.1093\/hmg\/ddi319","volume":"14","author":"IS Seong","year":"2005","unstructured":"Seong, I. S. et al. HD CAG repeat implicates a dominant property of huntingtin in mitochondrial energy metabolism. Hum. Mol. Genet 14, 2871\u20132880 (2005).","journal-title":"Hum. Mol. Genet"},{"key":"39552_CR88","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.stemcr.2017.01.022","volume":"8","author":"X Xu","year":"2017","unstructured":"Xu, X. et al. Reversal of phenotypic abnormalities by CRISPR\/Cas9-mediated gene correction in huntington disease patient-derived induced pluripotent stem cells. Stem Cell Rep 8, 619\u2013633 (2017).","journal-title":"Stem Cell Rep"},{"key":"39552_CR89","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1038\/ng.2732","volume":"45","author":"RP Mason","year":"2013","unstructured":"Mason, R. P. et al. Glutathione peroxidase activity is neuroprotective in models of Huntington\u2019s disease. Nat. Genet. 45, 1249\u20131254 (2013).","journal-title":"Nat. Genet."},{"key":"39552_CR90","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/nn.4532","volume":"20","author":"RG Lim","year":"2017","unstructured":"Lim, R. G. et al. Developmental alterations in Huntington\u2019s disease neural cells and pharmacological rescue in cells and mice. Nat. Neurosci. 20, 648\u2013660 (2017).","journal-title":"Nat. Neurosci."},{"key":"39552_CR91","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16205-9","volume":"11","author":"I Zorzan","year":"2020","unstructured":"Zorzan, I. et al. The transcriptional regulator ZNF398 mediates pluripotency and epithelial character downstream of TGF-beta in human PSCs. Nat. Commun. 11, 2364 (2020).","journal-title":"Nat. Commun."},{"key":"39552_CR92","doi-asserted-by":"publisher","first-page":"8299","DOI":"10.1073\/pnas.1014041108","volume":"108","author":"W Li","year":"2011","unstructured":"Li, W. et al. Rapid induction and long-term self-renewal of primitive neural precursors from human embryonic stem cells by small molecule inhibitors. Proc. Natl. Acad. Sci. 108, 8299\u20138304 (2011).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"39552_CR93","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S0168-9525(03)00074-X","volume":"19","author":"KL Sugars","year":"2003","unstructured":"Sugars, K. L. & Rubinsztein, D. C. Transcriptional abnormalities in Huntington disease. Trends Genet 19, 233\u2013238 (2003).","journal-title":"Trends Genet"},{"key":"39552_CR94","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/ng1542","volume":"37","author":"F Giorgini","year":"2005","unstructured":"Giorgini, F., Guidetti, P., Nguyen, Q., Bennett, S. C. & Muchowski, P. J. A genomic screen in yeast implicates kynurenine 3-monooxygenase as a therapeutic target for Huntington\u2019s disease. Nat. Genet. 37, 526\u2013531 (2005).","journal-title":"Nat. Genet."},{"key":"39552_CR95","doi-asserted-by":"publisher","first-page":"6403","DOI":"10.1073\/pnas.0307697101","volume":"101","author":"EAA Nollen","year":"2004","unstructured":"Nollen, E. A. A. et al. Genome-wide RNA interference screen identifies previously undescribed regulators of polyglutamine aggregation. Proc. Natl. Acad. Sci. 101, 6403\u20136408 (2004).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"39552_CR96","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.cell.2011.05.020","volume":"145","author":"D Zwilling","year":"2011","unstructured":"Zwilling, D. et al. Kynurenine 3-Monooxygenase Inhibition in Blood Ameliorates Neurodegeneration. Cell 145, 863\u2013874 (2011).","journal-title":"Cell"},{"key":"39552_CR97","doi-asserted-by":"publisher","first-page":"10720","DOI":"10.1523\/JNEUROSCI.2126-08.2008","volume":"28","author":"CL Benn","year":"2008","unstructured":"Benn, C. L. et al. Huntingtin Modulates Transcription, Occupies Gene Promoters In Vivo, and Binds Directly to DNA in a Polyglutamine-Dependent Manner. J. Neurosci. 28, 10720\u201310733 (2008).","journal-title":"J. Neurosci."},{"key":"39552_CR98","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.pneurobio.2007.03.004","volume":"83","author":"J-HJ Cha","year":"2007","unstructured":"Cha, J.-H. J. Transcriptional signatures in Huntington\u2019s disease. Prog. Neurobiol. 83, 228\u2013248 (2007).","journal-title":"Prog. Neurobiol."},{"key":"39552_CR99","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1002\/j.1460-2075.1993.tb05780.x","volume":"12","author":"F Radtke","year":"1993","unstructured":"Radtke, F. et al. Cloned transcription factor MTF-1 activates the mouse metallothionein I promoter. EMBO J 12, 1355\u20131362 (1993).","journal-title":"EMBO J"},{"key":"39552_CR100","doi-asserted-by":"publisher","first-page":"3167","DOI":"10.1093\/nar\/22.15.3167","volume":"22","author":"E Brugnera","year":"1994","unstructured":"Brugnera, E. et al. Cloning, chromosomal mapping and characterization of the human metal-regulatory transcription factor MTF-1. Nucleic Acids Res 22, 3167\u20133173 (1994).","journal-title":"Nucleic Acids Res"},{"key":"39552_CR101","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1006\/bbrc.2002.6517","volume":"291","author":"W-Y Chen","year":"2002","unstructured":"Chen, W.-Y., John, J. A. C., Lin, C.-H. & Chang, C.-Y. Molecular cloning and developmental expression of zinc finger transcription factor MTF-1 gene in zebrafish, Danio rerio. Biochem. Biophys. Res. Commun. 291, 798\u2013805 (2002).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"39552_CR102","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.aquatox.2010.03.017","volume":"99","author":"AP-L Cheung","year":"2010","unstructured":"Cheung, A. P.-L., Au, C. Y.-M., Chan, W. W.-L. & Chan, K. M. Characterization and localization of metal-responsive-element-binding transcription factors from tilapia. Aquat. Toxicol. Amst. Neth. 99, 42\u201355 (2010).","journal-title":"Aquat. Toxicol. Amst. Neth."},{"key":"39552_CR103","doi-asserted-by":"publisher","first-page":"4505","DOI":"10.1128\/MCB.21.14.4505-4514.2001","volume":"21","author":"B Zhang","year":"2001","unstructured":"Zhang, B., Egli, D., Georgiev, O. & Schaffner, W. The Drosophila homolog of mammalian zinc finger factor MTF-1 activates transcription in response to heavy metals. Mol. Cell. Biol. 21, 4505\u20134514 (2001).","journal-title":"Mol. Cell. Biol."},{"key":"39552_CR104","doi-asserted-by":"publisher","DOI":"10.1186\/s41240-017-0055-y","volume":"20","author":"SY Lee","year":"2017","unstructured":"Lee, S. Y. & Nam, Y. K. Molecular cloning of metal-responsive transcription factor-1 (MTF-1) and transcriptional responses to metal and heat stresses in Pacific abalone, Haliotis discus hannai. Fish. Aquat. Sci. 20, 9 (2017).","journal-title":"Fish. Aquat. Sci."},{"key":"39552_CR105","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.aquatox.2015.05.023","volume":"165","author":"J Meng","year":"2015","unstructured":"Meng, J. et al. Transcription factor CgMTF-1 regulates CgZnT1 and CgMT expression in Pacific oyster (Crassostrea gigas) under zinc stress. Aquat. Toxicol. Amst. Neth. 165, 179\u2013188 (2015).","journal-title":"Aquat. Toxicol. Amst. Neth."},{"key":"39552_CR106","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1515\/BC.2004.074","volume":"385","author":"K Balamurugan","year":"2004","unstructured":"Balamurugan, K. et al. Metal-responsive transcription factor (MTF-1) and heavy metal stress response in Drosophila and mammalian cells: a functional comparison. Biol. Chem 385, 597\u2013603 (2004).","journal-title":"Biol. Chem"},{"key":"39552_CR107","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/nrm2295","volume":"9","author":"I De Domenico","year":"2008","unstructured":"De Domenico, I., McVey Ward, D. & Kaplan, J. Regulation of iron acquisition and storage: consequences for iron-linked disorders. Nat. Rev. Mol. Cell Biol. 9, 72\u201381 (2008).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"39552_CR108","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3389\/fphar.2014.00099","volume":"5","author":"S Levi","year":"2014","unstructured":"Levi, S. & Finazzi, D. Neurodegeneration with brain iron accumulation: update on pathogenic mechanisms. Front. Pharmacol. 5, 99 (2014).","journal-title":"Front. Pharmacol."},{"key":"39552_CR109","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1111\/jnc.12739","volume":"130","author":"M Muller","year":"2014","unstructured":"Muller, M. & Leavitt, B. R. Iron dysregulation in Huntington\u2019s disease. J. Neurochem. 130, 328\u2013350 (2014).","journal-title":"J. Neurochem."},{"key":"39552_CR110","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.neuro.2019.07.007","volume":"74","author":"L Mezzaroba","year":"2019","unstructured":"Mezzaroba, L., Alfieri, D. F., Colado Sim\u00e3o, A. N. & Vissoci Reiche, E. M. The role of zinc, copper, manganese and iron in neurodegenerative diseases. Neurotoxicology 74, 230\u2013241 (2019).","journal-title":"Neurotoxicology"},{"key":"39552_CR111","doi-asserted-by":"publisher","DOI":"10.1038\/srep36669","volume":"6","author":"J-Y Wang","year":"2016","unstructured":"Wang, J.-Y. et al. Meta-analysis of brain iron levels of Parkinson\u2019s disease patients determined by postmortem and MRI measurements. Sci. Rep. 6, 36669 (2016).","journal-title":"Sci. Rep."},{"key":"39552_CR112","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1002\/hbm.22612","volume":"36","author":"C S\u00e1nchez\u2010Casta\u00f1eda","year":"2014","unstructured":"S\u00e1nchez\u2010Casta\u00f1eda, C. et al. The role of iron in gray matter degeneration in Huntington\u2019s disease: A magnetic resonance imaging study. Hum. Brain Mapp. 36, 50\u201366 (2014).","journal-title":"Hum. Brain Mapp."},{"key":"39552_CR113","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.1002\/hbm.22391","volume":"35","author":"M Di Paola","year":"2014","unstructured":"Di Paola, M. et al. MRI measures of corpus callosum iron and myelin in early Huntington\u2019s disease. Hum. Brain Mapp. 35, 3143\u20133151 (2014).","journal-title":"Hum. Brain Mapp."},{"key":"39552_CR114","doi-asserted-by":"publisher","first-page":"118535","DOI":"10.1016\/j.bbamcr.2019.118535","volume":"1866","author":"D Galaris","year":"2019","unstructured":"Galaris, D., Barbouti, A. & Pantopoulos, K. Iron homeostasis and oxidative stress: An intimate relationship. Biochim. Biophys. Acta BBA - Mol. Cell Res. 1866, 118535 (2019).","journal-title":"Biochim. Biophys. Acta BBA - Mol. Cell Res."},{"key":"39552_CR115","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1089\/ars.2017.7493","volume":"29","author":"C Moreau","year":"2018","unstructured":"Moreau, C. et al. Could Conservative Iron Chelation Lead to Neuroprotection in Amyotrophic Lateral Sclerosis?\u00a0Antioxid. Redox Signal 29, 742\u2013748 (2018).","journal-title":"Antioxid. Redox Signal"},{"key":"39552_CR116","doi-asserted-by":"publisher","first-page":"S379","DOI":"10.3233\/JAD-179944","volume":"64","author":"DJR Lane","year":"2018","unstructured":"Lane, D. J. R., Ayton, S. & Bush, A. I. Iron and Alzheimer\u2019s Disease: An Update on Emerging Mechanisms. J. Alzheimers Dis. 64, S379\u2013S395 (2018).","journal-title":"J. Alzheimers Dis."},{"key":"39552_CR117","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.3233\/JAD-170601","volume":"61","author":"C Kaindlstorfer","year":"2018","unstructured":"Kaindlstorfer, C. et al. The Relevance of Iron in the Pathogenesis of Multiple System Atrophy: A Viewpoint. J. Alzheimers Dis. 61, 1253\u20131273 (2018).","journal-title":"J. Alzheimers Dis."},{"key":"39552_CR118","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.parkreldis.2017.09.020","volume":"45","author":"SH Lee","year":"2017","unstructured":"Lee, S. H., Lyoo, C. H., Ahn, S. J., Rinne, J. O. & Lee, M. S. Brain regional iron contents in progressive supranuclear palsy. Parkinsonism Relat. Disord. 45, 28\u201332 (2017).","journal-title":"Parkinsonism Relat. Disord."},{"key":"39552_CR119","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.toxrep.2017.03.005","volume":"4","author":"B Fern\u00e1ndez","year":"2017","unstructured":"Fern\u00e1ndez, B., Ferrer, I., Gil, F. & Hilfiker, S. Biomonitorization of iron accumulation in the substantia nigra from Lewy body disease patients. Toxicol. Rep. 4, 188\u2013193 (2017).","journal-title":"Toxicol. Rep."},{"key":"39552_CR120","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1002\/mds.21020","volume":"21","author":"D Berg","year":"2006","unstructured":"Berg, D. & Hochstrasser, H. Iron metabolism in Parkinsonian syndromes. Mov. Disord. 21, 1299\u20131310 (2006).","journal-title":"Mov. Disord."},{"key":"39552_CR121","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1176\/jnp.1.4.400","volume":"1","author":"CE Coffey","year":"1989","unstructured":"Coffey, C. E., Alston, S., Heinz, E. R. & Burger, P. C. Brain iron in progressive supranuclear palsy: Clinical, magnetic resonance imaging, and neuropathological findings. J. Neuropsychiatry Clin. Neurosci. 1, 400\u2013404 (1989).","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"39552_CR122","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1128\/MCB.05207-11","volume":"31","author":"N Saini","year":"2011","unstructured":"Saini, N., Georgiev, O. & Schaffner, W. The parkin Mutant Phenotype in the Fly Is Largely Rescued by Metal-Responsive Transcription Factor (MTF-1) \u25bf. Mol. Cell. Biol. 31, 2151\u20132161 (2011).","journal-title":"Mol. Cell. Biol."},{"key":"39552_CR123","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/mt.2011.237","volume":"20","author":"DE Bowles","year":"2012","unstructured":"Bowles, D. E. et al. Phase 1 Gene Therapy for Duchenne Muscular Dystrophy Using a Translational Optimized AAV Vector. Mol. Ther. 20, 443\u2013455 (2012).","journal-title":"Mol. Ther."},{"key":"39552_CR124","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1089\/104303402760128612","volume":"13","author":"C Janson","year":"2002","unstructured":"Janson, C. et al. Gene Therapy of Canavan Disease: AAV-2 Vector for Neurosurgical Delivery of Aspartoacylase Gene (ASPA) to the Human Brain. Hum. Gene Ther. 13, 1391\u20131412 (2002).","journal-title":"Hum. Gene Ther."},{"key":"39552_CR125","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1016\/S0140-6736(07)60982-9","volume":"369","author":"MG Kaplitt","year":"2007","unstructured":"Kaplitt, M. G. et al. Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson\u2019s disease: an open label, phase I trial. The Lancet 369, 2097\u20132105 (2007).","journal-title":"The Lancet"},{"key":"39552_CR126","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1146\/annurev-virology-031413-085355","volume":"1","author":"RJ Samulski","year":"2014","unstructured":"Samulski, R. J. & Muzyczka, N. AAV-Mediated Gene Therapy for Research and Therapeutic Purposes. Annu. Rev. Virol. 1, 427\u2013451 (2014).","journal-title":"Annu. Rev. Virol."},{"key":"39552_CR127","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1016\/j.ymthe.2005.08.008","volume":"12","author":"GM Acland","year":"2005","unstructured":"Acland, G. M. et al. Long-term restoration of rod and cone vision by single dose rAAV-mediated gene transfer to the retina in a canine model of childhood blindness. Mol. Ther. J. Am. Soc. Gene Ther. 12, 1072\u20131082 (2005).","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"39552_CR128","doi-asserted-by":"publisher","first-page":"14083","DOI":"10.1073\/pnas.94.25.14083","volume":"94","author":"RJ Mandel","year":"1997","unstructured":"Mandel, R. J., Spratt, S. K., Snyder, R. O. & Leff, S. E. Midbrain injection of recombinant adeno-associated virus encoding rat glial cell line-derived neurotrophic factor protects nigral neurons in a progressive 6-hydroxydopamine-induced degeneration model of Parkinson\u2019s disease in rats. Proc. Natl. Acad. Sci. USA. 94, 14083\u201314088 (1997).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"39552_CR129","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1089\/hum.2017.133","volume":"29","author":"J Torres-Torronteras","year":"2017","unstructured":"Torres-Torronteras, J. et al. Long-Term Sustained Effect of Liver-Targeted Adeno-Associated Virus Gene Therapy for Mitochondrial Neurogastrointestinal Encephalomyopathy. Hum. Gene Ther. 29, 708\u2013718 (2017).","journal-title":"Hum. Gene Ther."},{"key":"39552_CR130","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1056\/NEJMoa1900907","volume":"380","author":"SJ Tabrizi","year":"2019","unstructured":"Tabrizi, S. J. et al. Targeting Huntingtin Expression in Patients with Huntington\u2019s Disease. N. Engl. J. Med. 380, 2307\u20132316 (2019).","journal-title":"N. Engl. J. Med."},{"key":"39552_CR131","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1016\/j.stemcr.2017.04.013","volume":"8","author":"R Brulet","year":"2017","unstructured":"Brulet, R. et al. NEUROD1 Instructs Neuronal Conversion in Non-Reactive Astrocytes. Stem Cell Rep 8, 1506\u20131515 (2017).","journal-title":"Stem Cell Rep"},{"key":"39552_CR132","doi-asserted-by":"publisher","first-page":"9336","DOI":"10.1523\/JNEUROSCI.3975-14.2015","volume":"35","author":"Y Liu","year":"2015","unstructured":"Liu, Y. et al. Ascl1 Converts Dorsal Midbrain Astrocytes into Functional Neurons In Vivo. J. Neurosci. 35, 9336\u20139355 (2015).","journal-title":"J. Neurosci."},{"key":"39552_CR133","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/nbt.3835","volume":"35","author":"P Rivetti di Val Cervo","year":"2017","unstructured":"Rivetti di Val Cervo, P. et al. Induction of functional dopamine neurons from human astrocytes in vitro and mouse astrocytes in a Parkinson\u2019s disease model. Nat. Biotechnol. 35, 444\u2013452 (2017).","journal-title":"Nat. Biotechnol."},{"key":"39552_CR134","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14855-3","volume":"11","author":"Z Wu","year":"2020","unstructured":"Wu, Z. et al. Gene therapy conversion of striatal astrocytes into GABAergic neurons in mouse models of Huntington\u2019s disease. Nat. Commun. 11, 1105 (2020).","journal-title":"Nat. Commun."},{"key":"39552_CR135","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1172\/JCI92087","volume":"127","author":"S Yang","year":"2017","unstructured":"Yang, S. et al. CRISPR\/Cas9-mediated gene editing ameliorates neurotoxicity in mouse model of Huntington\u2019s disease. J. Clin. Invest 127, 2719\u20132724 (2017).","journal-title":"J. Clin. Invest"},{"key":"39552_CR136","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1056\/NEJMoa1706198","volume":"377","author":"JR Mendell","year":"2017","unstructured":"Mendell, J. R. et al. Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy. N. Engl. J. Med. 377, 1713\u20131722 (2017).","journal-title":"N. Engl. J. Med."},{"key":"39552_CR137","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/BF00376370","volume":"198","author":"AH Handyside","year":"1989","unstructured":"Handyside, A. H., O\u2019Neill, G. T., Jones, M. & Hooper, M. L. Use of BRL-conditioned medium in combination with feeder layers to isolate a diploid embryonal stem cell line. Rouxs Arch. Dev. Biol. Off. Organ EDBO 198, 48\u201356 (1989).","journal-title":"Rouxs Arch. Dev. Biol. Off. Organ EDBO"},{"key":"39552_CR138","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/nmeth.1593","volume":"8","author":"G Chen","year":"2011","unstructured":"Chen, G. et al. Chemically defined conditions for human iPS cell derivation and culture. Nat. Methods 8, 424\u2013429 (2011).","journal-title":"Nat. Methods"},{"key":"39552_CR139","doi-asserted-by":"publisher","first-page":"e10168","DOI":"10.1371\/journal.pone.0010168","volume":"5","author":"CJ Potter","year":"2010","unstructured":"Potter, C. J. & Luo, L. Splinkerette PCR for Mapping Transposable Elements in Drosophila. PLOS ONE 5, e10168 (2010).","journal-title":"PLOS ONE"},{"key":"39552_CR140","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-14892-x","volume":"7","author":"Y Xiong","year":"2017","unstructured":"Xiong, Y. et al. A Comparison of mRNA Sequencing with Random Primed and 3\u2032-Directed Libraries. Sci. Rep. 7, 14626 (2017).","journal-title":"Sci. Rep."},{"key":"39552_CR141","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon, P. et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13, 2498\u20132504 (2003).","journal-title":"Genome Res"},{"key":"39552_CR142","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinforma. Oxf. Engl. 29, 15\u201321 (2013).","journal-title":"Bioinforma. Oxf. Engl."},{"key":"39552_CR143","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","volume":"31","author":"S Anders","year":"2015","unstructured":"Anders, S., Pyl, P. T. & Huber, W. HTSeq\u2013a Python framework to work with high-throughput sequencing data. Bioinforma. Oxf. Engl 31, 166\u2013169 (2015).","journal-title":"Bioinforma. Oxf. Engl"},{"key":"39552_CR144","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 15, 550 (2014).","journal-title":"Genome Biol"},{"key":"39552_CR145","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinforma. Oxf. Engl. 26, 139\u2013140 (2010).","journal-title":"Bioinforma. Oxf. Engl."},{"key":"39552_CR146","doi-asserted-by":"publisher","first-page":"e1010604","DOI":"10.1371\/journal.pcbi.1010604","volume":"18","author":"M Locard-Paulet","year":"2022","unstructured":"Locard-Paulet, M., Palasca, O. & Jensen, L. J. Identifying the genes impacted by cell proliferation in proteomics and transcriptomics studies. PLOS Comput. Biol. 18, e1010604 (2022).","journal-title":"PLOS Comput. Biol."},{"key":"39552_CR147","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA. 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"39552_CR148","doi-asserted-by":"publisher","first-page":"D165","DOI":"10.1093\/nar\/gkab1113","volume":"50","author":"JA Castro-Mondragon","year":"2022","unstructured":"Castro-Mondragon, J. A. et al. JASPAR 2022: the 9th release of the open-access database of transcription factor binding profiles. Nucleic Acids Res 50, D165\u2013D173 (2022).","journal-title":"Nucleic Acids Res"},{"key":"39552_CR149","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/msb.2011.75","volume":"7","author":"F Sievers","year":"2011","unstructured":"Sievers, F. et al. Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Mol. Syst. Biol. 7, 539 (2011).","journal-title":"Mol. Syst. Biol."},{"key":"39552_CR150","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0165-0270(02)00012-2","volume":"115","author":"GA Metz","year":"2002","unstructured":"Metz, G. A. & Whishaw, I. Q. Cortical and subcortical lesions impair skilled walking in the ladder rung walking test: a new task to evaluate fore- and hindlimb stepping, placing, and co-ordination. J. Neurosci. Methods 115, 169\u2013179 (2002).","journal-title":"J. Neurosci. Methods"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-39552-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-39552-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-39552-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T09:03:28Z","timestamp":1688547808000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-39552-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,5]]},"references-count":150,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["39552"],"URL":"https:\/\/doi.org\/10.1038\/s41467-023-39552-9","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,5]]},"assertion":[{"value":"31 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"G.M.F., A.M.G., M.Le. and G.M., files a patent application about the use of the suppressors identified in this study as therapeutic agents for polyQ diseases (Therapeutic factors for the treatment of PolyQ disease - Patent Application No. PCT\/IB2023\/051156 filed on 11 February 2022). Patent applicants are the institutions of Telethon Foundation, University of Padova and University of Wien. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3962"}}